PATHOGENESIS OF LUNG INJURY IN LUNG AND PERITONEAL SEPSIS
PATHOGENESIS OF LUNG INJURY IN LUNG AND PERITONEAL SEPSIS
批准号:
6302182
负责人:
Thomas R Martin
金额:
$19.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30
关键词:
Escherichia coli adult respiratory distress syndrome bacterial disease bacterial pneumonia bactericidal immunity blood toxicology cytokine disease /disorder model endotoxins host neoplasm interaction immunocytochemistry inflammation laboratory rabbit lung injury neutrophil pathologic process peritonitis respiratory epithelium respiratory infections
中文摘要
有问题。这个项目将研究细胞和分子事件
将初级身体空间的局部感染与全身感染联系起来
对远处器官的后果和伤害。主要的假设是一个
三室模型最好地解释了人类对细菌的反应
以及他们的产品。在这个模型中,细菌进入初始隔间
(如肺部或腹腔),以及细菌之间的局部相互作用
宿主效应系统决定着细菌是否有效地
被淘汰了。当第一隔室反应无效时,反应
发生在第二个“全身”隔室。当第二个车厢
反应严重,反应发生在第三隔间(远处
器官)。在肺部,这些反应包括对上皮细胞的损伤
障碍和持续的功能丧失。我们将调查重要的
与理解此模型相关的问题。重大的长期
目标是了解第二个和第三个隔间的反应
可以最小化,而不会对细菌在
第一个车厢。
明确的目标。1)研究“第一隔室”反应。
肺和腹膜腔,以确定为什么
这两个部位的“间隔”反应不同;2)至
调查第一个隔间之间的关键相互关系
和第二间隔炎性反应;3)研究
第三肺上皮损伤的发生机制
4)研究保护第三方的策略
不会对体内的抗菌反应产生不利影响
第一个车厢。
实验方法。我们将研究肺炎或腹膜炎的兔子
由于感染了大肠杆菌,并在感染后跟踪他们长达24小时。
第一个隔室的反应将与全身反应进行比较
生理和炎症反应变量,以及测量
第三隔室(肺)的功能和解剖完整性。新的
保护第三隔间而不妥协的策略
将对第一隔间的抗菌防御进行调查。
意义重大。这些研究将提供有关
肺局部和全身反应与肺损伤的关系
脓毒症,并将有助于确定预防的最佳方法
而脓毒症并发症的治疗是专注于特定的微生物
(例如,更好的抗生素),或干扰宿主反应
(例如,更好的抗炎治疗),或者两者兼而有之。
英文摘要
Problem. This project will investigate the cellular and molecular events
that link local infection in a primary body space with systemic
consequences and injury to distant organs. The major hypothesis is that a
three compartment model best explains the responses of humans to bacteria
and their products. In this model, bacteria enter an initial compartment
(e.g., lungs or abdominal cavity), and local interactions between bacteria
and host effector systems govern whether bacteria are effectively
eliminated. When first compartment responses are ineffective, responses
occur in the second "systemic" compartment. When the second compartment
responses are severe, responses occur in the third compartment (distant
organs). In the lungs these responses include injury to the epithelial
barrier and sustained loss of function. We will investigate important
questions that relate to understanding this model. The major long-term
goal is to understand how responses in the second and third compartments
can be minimized without adversely affecting bacterial elimination in the
first compartment.
Specific Aims. 1) to investigate the "first compartment" responses in the
lungs and the peritoneal cavity, in order to determine why the "first
compartment" responses differ in each of these two sites; 2) to
investigate the critical inter-relationships between the first compartment
and the second compartment inflammatory responses; 3) to investigate the
mechanisms by which injury occurs to the lung epithelium in the third
compartment; 4) to investigate strategies that will protect the third
compartment without adversely affecting antibacterial responses in the
first compartment.
Experimental approach. We will study rabbits with pneumonia or peritonitis
due to E. coli, and follow them for up to 24 hours after infection.
Responses in the first compartment will be compared with systemic
physiologic and inflammatory response variables, and measurements of
functional and anatomic integrity of the third compartment (lungs). New
strategies to protect the third compartment without compromising
antibacterial defenses in the first compartment will be investigated.
Significance. These studies will provide information about the
relationship between local and systemic responses and lung injury in
sepsis, and will help to determine whether the best approach to prevention
and treatment of septic complications is to focus on the specific organism
(e.g., better antibiotics), or on interfering with the host response
(e.g., better anti-inflammatory therapy), or both.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Innate Immune Variation
-
批准号:8236986
-
项目类别:
-
资助金额:$46.78万
-
财政年份:2011
-
负责人:Thomas R Martin
-
依托单位:
Human Innate Immune Variation
-
批准号:7675894
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2009
-
负责人:Thomas R Martin
-
依托单位:
Variation in Human Innate Immunity
-
批准号:7638366
-
项目类别:
-
资助金额:$88.93万
-
财政年份:2008
-
负责人:Thomas R Martin
-
依托单位:
Acute Lung Injury: Link Between Apoptosis and Fibrosis
-
批准号:7496108
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2007
-
负责人:Thomas R Martin
-
依托单位:
Acute Lung Injury: Link Between Apoptosis and Fibrosis
-
批准号:7637452
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2007
-
负责人:Thomas R Martin
-
依托单位:
"Acute lung injury: link between apoptosis and fibrosis"
-
批准号:7198426
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2007
-
负责人:Thomas R Martin
-
依托单位:
SCCOR in Translational Research in Acute Lung Injury
-
批准号:6851348
-
项目类别:
-
资助金额:$3.43万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
SCCOR in Translational Research in Acute Lung Injury
-
批准号:6673301
-
项目类别:
-
资助金额:$291.59万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
Core A- Administrative Core
-
批准号:6820118
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
SCCOR in Translational Research in Acute Lung Injury
-
批准号:6936545
-
项目类别:
-
资助金额:$321.51万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
Core--Biotechnology
-
批准号:6820120
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
SCCOR in Translational Research in Acute Lung Injury
-
批准号:6935801
-
项目类别:
-
资助金额:$308.27万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
SCCOR in Translational Research in Acute Lung Injury
-
批准号:7281176
-
项目类别:
-
资助金额:$322.87万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
SCCOR in Translational Research in Acute Lung Injury
-
批准号:7111122
-
项目类别:
-
资助金额:$324.08万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
Host Determinants of the inflammatory response
-
批准号:6820109
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2003
-
负责人:Thomas R Martin
-
依托单位:
Molecular Mechanisms of Lung Inflammation
-
批准号:6470319
-
项目类别:
-
资助金额:$9.07万
-
财政年份:2002
-
负责人:Thomas R Martin
-
依托单位:
PATHOGENESIS OF LUNG INJURY IN LUNG AND PERITONEAL SEPSIS
-
批准号:6564876
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2001
-
负责人:Thomas R Martin
-
依托单位:
MOLECULAR MECHANISMS OF LUNG INJURY IN SEPSIS
-
批准号:6413615
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2001
-
负责人:Thomas R Martin
-
依托单位:
MOLECULAR MECHANISMS OF LUNG INJURY IN SEPSIS
-
批准号:6395881
-
项目类别:
-
资助金额:$15.89万
-
财政年份:2000
-
负责人:Thomas R Martin
-
依托单位:
MOLECULAR MECHANISMS OF LUNG INJURY IN SEPSIS
-
批准号:6107526
-
项目类别:
-
资助金额:$15.89万
-
财政年份:1999
-
负责人:Thomas R Martin
-
依托单位:
海外基金